- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07595991
Post-osteoporotic Fracture Exercise Program
Community Osteoporosis Exercise Class for People Post Fracture
Those with osteoporosis often have weaker bones and this leads to higher chances of fractures. Therefore, the investigators want to evaluate the feasibility and safety of group exercise classes specifically designed for individuals with osteoporosis who had an osteoporotic fracture. By focusing on this high-risk population, the investigators want to see whether such exercise interventions can be an option for improving bone health, reducing the risk of future fractures, and enhancing physical function without compromising safety.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Christina Ziebart, PT, PhD
- Telefoonnummer: 88850 519-661-2111
- E-mail: cziebart@uwo.ca
Studie Contact Back-up
- Naam: Abigail Mitchell, BSc
- Telefoonnummer: 709-727-2762
- E-mail: amitc57@uwo.ca
Studie Locaties
-
-
Ontario
-
London, Ontario, Canada, N6G 1H1
- Werving
- Canadian Centre for Activity and Aging
-
Contact:
- Christina Ziebart, PT, PhD
- Telefoonnummer: 88850 519-661-2111
- E-mail: cziebart@uwo.ca
-
Contact:
- Steve Di Ciacca, MSc, BSc(PT), BHKin
- Telefoonnummer: 81609 519 661-1603
- E-mail: sdiciacc@uwo.ca
-
Hoofdonderzoeker:
- Christina Ziebart, PT, PhD
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Diagnosed with osteoporosis.
- History of low trauma fracture within the past year
- Cleared for physical activity using the get active questionnaire, 100 bpm resting heart rate or less, 160 mm Hg diastolic blood pressure or less
- Able to understand and provide informed consent.
- Residing within the study's geographic area (e.g., London, Ontario).
Exclusion Criteria:
- Individuals who do not understand the English language
- Medical conditions contraindicating participation in exercise (e.g., uncontrolled cardiovascular disease, severe respiratory illness).
- Cognitive impairments that prevent informed consent or participation.
- Recent major surgeries or medical events limiting physical activity.
- Participation in conflicting clinical trials or rehabilitation programs.
- Residents outside the designated study area.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: NVT
- Interventioneel model: Opdracht voor een enkele groep
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Experimental Arm for Feasibility study
Feasibility Intervention |
Participants complete a 12-week, twice weekly, whole body group exercise program. Participants will also complete qualitative interviews and DXA bone scans. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Recruitment Feasibility
Tijdsspanne: Assessed over 12 months
|
Recruitment feasibility will be assessed by the number of participants enrolled in the study over a 12-month recruitment period. The target recruitment goal is 100 participants. |
Assessed over 12 months
|
|
Retention Feasibility
Tijdsspanne: Assessed at 12 weeks
|
Retention feasibility will be assessed as the percentage of enrolled participants who complete the 12-week reassessment. The predefined retention target is 60%. Percentages range from 0% to 100%, with higher percentages indicating better retention feasibility. |
Assessed at 12 weeks
|
|
Exercise Class Adherence
Tijdsspanne: Assessed over the 12-week intervention period
|
Exercise adherence will be assessed using class attendance records. Adherence will be calculated as the percentage of scheduled exercise sessions attended by each participant. The predefined adherence target is 80%. Percentages range from 0% to 100%, with higher percentages indicating better adherence. |
Assessed over the 12-week intervention period
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Program Acceptability
Tijdsspanne: Assessed at 12 weeks
|
Program acceptability will be assessed using participant exit interviews conducted at the completion of the intervention. Acceptability will be calculated as the percentage of participants who report a positive response regarding satisfaction with the program. The predefined acceptability target is 80%. Percentages range from 0% to 100%, with higher percentages indicating greater program acceptability. |
Assessed at 12 weeks
|
|
Intervention Safety
Tijdsspanne: Assessed throughout the 12-week intervention period
|
Intervention safety will be assessed by recording the number and type of adverse events attributable to the intervention, including falls, musculoskeletal pain, prolonged muscle soreness, dizziness, fainting, shortness of breath, and other participant-reported medical concerns. Lower numbers indicate better intervention safety. |
Assessed throughout the 12-week intervention period
|
Andere uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in Bone Quality
Tijdsspanne: Baseline and 12 weeks
|
Bone quality will be assessed using dual-energy X-ray absorptiometry (DXA), including Trabecular Bone Score assessment of bone microarchitecture. Higher bone mineral density and Trabecular Bone Score values indicate better bone health and bone microarchitecture. |
Baseline and 12 weeks
|
|
Change in health care utilization
Tijdsspanne: Assessed over the 6-month period following completion of the exercise program
|
Health care utilization will be assessed using Institute for Clinical Evaluative Sciences (ICES) health administrative records. Measures of health care utilization may include health care visits, hospitalizations, and fracture-related health service use following participation in the exercise program. Lower health care utilization and fewer fracture-related events may indicate improved health outcomes. |
Assessed over the 6-month period following completion of the exercise program
|
|
Change in Physical Function
Tijdsspanne: Baseline, 6 weeks, and 12 weeks
|
Physical function will be assessed using the Short Physical Performance Battery. Scores range from 0 to 12, with higher scores indicating better lower extremity physical function. |
Baseline, 6 weeks, and 12 weeks
|
|
Change in Functional Exercise Capacity
Tijdsspanne: Baseline, 6 weeks, and 12 weeks
|
Functional exercise capacity will be assessed using the 6-Minute Walk Test. Distance will be measured in meters, with greater distances indicating better functional exercise capacity. |
Baseline, 6 weeks, and 12 weeks
|
|
Change in Mobility
Tijdsspanne: Baseline, 6 weeks, and 12 weeks
|
Mobility will be assessed using the Timed Up and Go Test. Time will be measured in seconds, with lower times indicating better mobility and lower fall risk. |
Baseline, 6 weeks, and 12 weeks
|
|
Change in Single Leg Balance
Tijdsspanne: Baseline, 6 weeks, and 12 weeks
|
Static balance will be assessed using the Single Leg Balance Test. Time will be measured in seconds, with longer durations indicating better balance performance. |
Baseline, 6 weeks, and 12 weeks
|
|
Change in Osteoporosis-Specific Quality of Life
Tijdsspanne: Baseline, 6 weeks, 12 weeks, and 6 months
|
Quality of life will be assessed using the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Scores range from 0 to 100, with lower scores indicating better quality of life. |
Baseline, 6 weeks, 12 weeks, and 6 months
|
|
Change in Overall Health-Related Quality of Life
Tijdsspanne: Baseline, 6 weeks, 12 weeks, and 6 months
|
Health-related quality of life will be assessed using the EuroQol 5 Dimension (EQ-5D). Scores range from less than 0 to 1, with higher scores indicating better health-related quality of life. |
Baseline, 6 weeks, 12 weeks, and 6 months
|
|
Change in Physical Activity
Tijdsspanne: Baseline, 6 weeks, 12 weeks, and 6 months
|
Physical activity participation will be assessed using the Physical Activity Scale for the Elderly. Scores range from 0 to over 400, with higher scores indicating greater physical activity participation. |
Baseline, 6 weeks, 12 weeks, and 6 months
|
|
Change in Grip Strength
Tijdsspanne: Baseline, 6 weeks, and 12 weeks
|
Grip strength will be assessed using hand dynamometry. Grip strength will be measured in kilograms, with higher values indicating greater grip strength and upper extremity muscle function. |
Baseline, 6 weeks, and 12 weeks
|
Medewerkers en onderzoekers
Sponsor
Studie record data
Bestudeer belangrijke data
Studie start (Geschat)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
- Botziekten
- Musculoskeletale aandoeningen
- Wonden en verwondingen
- Metabole ziekten
- Breuken, bot
- Botziekten, Metabool
- Voedings- en stofwisselingsziekten
- Osteoporose
- Osteoporotische fracturen
- Motorische activiteit
- Beweging
- Musculoskeletale fysiologische fenomenen
- Musculoskeletale en neurale fysiologische fenomenen
- Therapeutica
- Modaliteiten fysiotherapie
- Patiëntenzorg
- Transporttherapie
- Revalidatie
- Nazorg
- Continuïteit van patiëntenzorg
- Fysieke conditionering, mens
- Oefening
- Weerstandstraining
Andere studie-ID-nummers
- 127410
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
Sharing of individual participant data will be upon request and only deidentified data will be shared
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .